US Stock IR Daily – April 30, 2026 (16 reports)

• The Cigna Group filed a Form 8-K with the U.S. Securities and Exchange Commission on April 30, 2026.
• This Form 8-K pertains to the company’s results of operations and financial condition.
• On April 30, 2026, The Cigna Group issued a press release announcing its financial results for the three months ended March 31, 2026.
• The aforementioned press release is furnished as Exhibit 99.1 to the Form 8-K.

This 8-K filing indicates that Cigna has formally released its quarterly financial results, making the detailed earnings information accessible to investors via the attached press release. This action signals that the company’s latest operational performance data is now publicly available. Market participants may now be reviewing the full press release for specific financial metrics and future guidance.

• Caterpillar Inc. filed a Form 8-K on April 30, 2026.
• The filing reported the company’s financial results for the quarter ended March 31, 2026.
• A press release detailing these financial results was issued on April 30, 2026, and attached as Exhibit 99.1.
• Supplemental information regarding retail sales of machines and power systems to end users and Original Equipment Manufacturers (“OEMs”) was also furnished as Exhibit 99.2.

This Form 8-K filing signifies the release of Caterpillar Inc.’s latest quarterly financial results. Investors seeking detailed financial performance, including revenue and earnings figures, would typically refer to the accompanying press release. Furthermore, the provided supplemental retail sales data could offer insights into market demand trends for the company’s products.

• Air Products & Chemicals, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on April 30, 2026.
• The company announced its “Results of Operations and Financial Condition” for the second quarter of fiscal year 2026.
• This earnings announcement was made through a press release dated April 30, 2026, which is furnished as Exhibit 99.1 to the Form 8-K.
• The report was signed by Melissa N. Schaeffer, Executive Vice President and Chief Financial Officer.

This announcement indicates that Air Products & Chemicals has disclosed its latest quarterly financial performance as part of its regular reporting schedule. Investors interested in the company’s operational results may find detailed figures, such as revenue and profit metrics, by reviewing the referenced press release (Exhibit 99.1) accompanying the Form 8-K. This filing serves to provide market transparency regarding the company’s recent financial activities.

• Merck & Co., Inc. (MRK) filed a Form 8-K on April 30, 2026.
• This filing pertains to Item 2.02, “Results of Operations and Financial Condition,” relating to the company’s first quarter of 2026 earnings.
• Merck issued a press release (Exhibit 99.1) on April 30, 2026, regarding its first quarter 2026 earnings, which is incorporated by reference in the 8-K document.
• Additionally, certain supplemental information not included in the press release (Exhibit 99.2) was also issued.
• Merck’s common stock is listed on the New York Stock Exchange (NYSE).

This Form 8-K filing confirms Merck’s official disclosure of its Q1 2026 earnings information to the market. Investors may now refer to the referenced press release and supplemental information for specific details on the company’s financial performance. Such periodic disclosures are a key event for market participants to assess a company’s current operational health and potential future trajectory.

• Eli Lilly and Company filed a Form 8-K with the U.S. Securities and Exchange Commission on April 30, 2026.
• This Form 8-K pertains to the company’s results of operations and financial condition for the quarter ended March 31, 2026.
• The company announced its financial results through a press release dated April 30, 2026, which was furnished as Exhibit 99.1 to the report.
• The report was signed by Donald A. Zakrowski, Senior Vice President, Finance, and Chief Accounting Officer.

Eli Lilly has submitted a Form 8-K related to its financial results for the first quarter of 2026. It is important to note that this filing primarily indicates the furnishing of the results, with the detailed financial figures and commentary expected to be contained within the referenced press release (Exhibit 99.1). Investors would likely focus on that press release for a comprehensive understanding of the company’s latest performance.

• Bristol-Myers Squibb Company filed a Form 8-K on April 30, 2026.
• The company announced its financial results for the first quarter of 2026.
• The earnings announcement was made via an Earnings Press Release published on the company’s website (www.bms.com) on April 30, 2026.
• A presentation for the company’s conference call and webcast, held on April 30, 2026, at 8:00 a.m. Eastern time, was also posted on its website.
• These announcement materials (the Earnings Press Release and Bristol Myers Presentation) are incorporated by reference as Exhibit 99.1 and 99.2, respectively, into the Form 8-K.

Bristol-Myers Squibb’s recent announcement provides investors with the latest financial information regarding its operations for the first quarter of 2026. The detailed press release and presentation published on the official website could be considered key resources for understanding the company’s most recent performance trends. The disclosure of non-GAAP financial information may also be a point of interest for analysts.

• Altria Group, Inc. filed a Form 8-K on April 30, 2026.
• The 8-K reports the issuance of a press release announcing financial results for the quarter ended March 31, 2026.
• The press release was issued on April 30, 2026, and is attached as Exhibit 99.1 to the 8-K.
• This information is furnished under Item 2.02, “Results of Operations and Financial Condition,” of the Form 8-K.

This 8-K filing serves as an official notification that Altria Group has released its latest quarterly financial results. While the specific financial details are contained in the referenced press release, investors will likely be monitoring these figures closely for insights into the company’s performance. The detailed results, once available, could provide key indicators for future analysis.

• Intercontinental Exchange, Inc. (ICE) filed a Form 8-K on April 30, 2026.
• The report announced ICE’s financial results for the fiscal quarter ended March 31, 2026.
• A press release detailing these financial results is attached as Exhibit 99.1 to the Form 8-K.
• The press release is noted to include non-GAAP financial information and a reconciliation to comparable GAAP financial measures.

This filing signals the company’s routine disclosure of its financial performance to the investment community. Investors may now refer to the attached press release for specific financial figures and operational insights, which could provide a foundation for evaluating ICE’s performance during the quarter. The inclusion of non-GAAP metrics, alongside GAAP reconciliation, often offers additional perspectives on the company’s financial health and underlying operational trends.

• Walmart Inc. entered into a Pricing Agreement on April 27, 2026, with several underwriters, including Citigroup Global Markets Inc., J.P. Morgan Securities LLC, and Mizuho Securities USA LLC.
• Under this agreement, Walmart committed to selling an aggregate principal amount of $4,250,000,000 in notes to the underwriters.
• The notes consist of Floating Rate Notes Due 2029 ($350,000,000), 4.000% Notes Due 2029 ($650,000,000), 4.150% Notes Due 2031 ($1,000,000,000), 4.450% Notes Due 2033 ($1,250,000,000), and 4.750% Notes Due 2036 ($1,000,000,000).
• The sale and purchase of these notes are expected to be consummated on April 30, 2026.

This note issuance may suggest Walmart’s strategy to raise substantial capital through a mix of fixed and floating rate debt with varying maturities. Such a move could indicate efforts to manage its balance sheet and fund ongoing operations or strategic investments. The diverse maturities offered might reflect an approach to optimize its capital structure in the prevailing interest rate environment.

• Parker-Hannifin Corporation filed a Form 8-K with the U.S. Securities and Exchange Commission on April 30, 2026.
• The Form 8-K reported that a press release announcing results of operations for the quarter ended March 31, 2026, was issued.
• The aforementioned press release is furnished as Exhibit 99.1 to the Form 8-K report.
• The date of the earliest event reported in the filing is April 30, 2026.

This filing indicates that Parker-Hannifin has made its latest quarterly financial information publicly available. Investors may wish to review the detailed press release, referenced as Exhibit 99.1, to gain insights into the company’s performance and financial health for the quarter ended March 31, 2026. Such disclosures are typically closely watched by the market as they can provide context for future business expectations.

• The Southern Company and its subsidiaries, including Alabama Power Company, Georgia Power Company, Mississippi Power Company, Southern Power Company, and Southern Company Gas, have filed a Form 8-K.
• The date of the earliest event reported in the filing is specified as April 30, 2026.
• The filing provides detailed information on various securities registered on the New York Stock Exchange (NYSE).
• For The Southern Company, registered securities include Common Stock, par value $5 per share (SO), multiple series of Junior Subordinated Notes (e.g., Series 2017B 5.25% due 2077, Series 2020A 4.95% due 2080), and 2025 Series A Corporate Units (SOMN).
• Georgia Power Company’s Series 2017A 5.00% Junior Subordinated Notes due 2077 (GPJA) are also listed as registered on the NYSE.
• Southern Power Company’s Series 2016B 1.850% Senior Notes due 2026 (SO/26A) are registered on the NYSE as well.

This announcement concerns a Form 8-K filing by Southern Company and its affiliated entities with the U.S. Securities and Exchange Commission. The document primarily outlines the various classes of common stock and different series of subordinated and senior notes that are registered on the New York Stock Exchange. Such regulatory filings are a standard practice, offering transparency into the company’s publicly traded financial instruments and providing an update on its overall capital structure for investors.

• Amgen Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC) on April 30, 2026.
• The 8-K reported that the company issued a press release on April 30, 2026, announcing its unaudited results of operations for the three months ended March 31, 2026, and its unaudited financial position as of March 31, 2026.
• The press release included non-GAAP financial measures such as non-GAAP earnings per share, non-GAAP operating income, and Free Cash Flow (FCF).
• Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures were provided in the press release.
• Amgen stated that these non-GAAP financial measures are used to provide useful supplementary information, facilitate additional analysis by investors, and for internal budgeting and financial planning.

Amgen’s announcement indicates a commitment to providing investors with a comprehensive view of its financial performance through both GAAP and non-GAAP metrics. The inclusion of non-GAAP measures and Free Cash Flow can offer insights into the company’s operational performance, excluding certain non-recurring or non-cash items. Investors may find it beneficial to analyze the reconciliations between GAAP and non-GAAP figures to understand the full financial context.

• Stryker Corporation (SYK) filed a Form 8-K with the SEC on April 30, 2026.
• The Form 8-K announced that the company issued a press release on April 30, 2026, detailing its first quarter 2026 operating results.
• This press release is furnished as Exhibit 99.1 to the Form 8-K filing.
• The information in the report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.

This 8-K filing indicates that Stryker has publicly disclosed its financial performance for the first quarter of 2026. Investors may find it beneficial to consult the full press release for detailed financial figures and management commentary to understand the company’s recent operational standing.

• Apple Inc. reported on April 30, 2026, that it issued a press release concerning its financial results for its second fiscal quarter ended March 28, 2026.
• This announcement was made through a Form 8-K (Current Report) filed with the U.S. Securities and Exchange Commission (SEC) on the same date.
• A copy of Apple’s press release is attached as Exhibit 99.1 to the Form 8-K.

The issuance of a press release detailing Apple’s quarterly financial results is a standard corporate disclosure that provides critical information for investors. Such announcements typically offer insights into the company’s performance over the reported period, including key financial metrics like revenue, net income, and segment-specific results. These figures are generally monitored by investors to assess operational health and strategic direction. The specific financial details would be available in the accompanying press release, which was noted in this 8-K filing.

• AT&T Inc. filed a Form 8-K Current Report dated April 30, 2026.
• The report details various securities of the company registered under Section 12(b) of the Securities Exchange Act of 1934.
• Registered securities include Common Shares (T), 5.000% Perpetual Preferred Stock, Series A (T PRA), and 4.750% Perpetual Preferred Stock, Series C (T PRC).
• Additionally, numerous series of Global Notes are listed, with various interest rates and maturity dates, such as the 0.250% Global Notes due March 4, 2026, and the 5.350% Global Notes due November 1, 2066.
• All listed securities are registered on the New York Stock Exchange (NYSE), with Common Shares also registered on NYSE Texas.

This 8-K filing appears to be a formal update or confirmation of AT&T’s publicly traded securities registered with the SEC. While the document itself does not announce new financial activities, it could be seen as providing transparency regarding the company’s capital structure and the various instruments available for trading on major exchanges. Investors typically monitor such filings to understand the company’s existing financial obligations and equity structure.

• On April 30, 2026, Intel Corporation issued an aggregate principal amount of $6.5 billion in Senior Notes.
• The issuance comprised five separate tranches:
• $1,000,000,000 of 4.650% Senior Notes due 2031
• $1,000,000,000 of 5.000% Senior Notes due 2033
• $2,250,000,000 of 5.300% Senior Notes due 2036
• $1,750,000,000 of 6.125% Senior Notes due 2056
• $500,000,000 of 6.200% Senior Notes due 2066
• The net proceeds from the offering amounted to approximately $6.47 billion, before expenses and after deducting underwriting discounts.
• The offering was conducted under an underwriting agreement dated April 27, 2026, with representatives including Citigroup Global Markets Inc. and J.P. Morgan Securities LLC.
• The notes were issued pursuant to Intel’s registration statement on Form S-3 filed on January 23, 2026.

This announcement indicates Intel’s successful execution of a significant debt offering to raise capital from the market. The issuance of notes across various maturities, stretching out to 2066, may suggest a strategy to secure long-term financing for ongoing or future corporate initiatives. The approximate $6.47 billion in net proceeds could provide Intel with substantial financial flexibility, potentially for capital expenditures, working capital, or refinancing existing debt.